People enrolled in early stage trials for possible cancer treatments may underestimate the risks involved and overestimate the potential benefits. Mary Faith Marshall, Medical School and Center for Bioethics, discusses ways to improve the informed consent process.
- Centers & Institutes (7)
- Schools / Colleges (8)
- University of Minnesota Physicians (210)
Join Us Online
Sign up for our email newsletter
Justin D. Paquette
Assistant Director of Public Relations